ProVADA steers a protein generator to adapt proteins to non-native biological contexts
ProVADA steered a pretrained protein generator to produce active, drug-inhibitable cytosolic renin and deimmunized two murine antibody fragments while retaining antigen recognition. ESCAPE-seq measured reduced HLA-I peptide binding, and redesigned FMC63 variants retained CAR-T-cell killing. This summary is limited to the abstract of the October 18, 2026 version 2 preprint; the initial preprint dates to July 17, 2025.
Technology: ProVADA (Mixture-Adaptation Directed Annealing sampler steering a pretrained protein generator)
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: Renin activity/inhibitor response, antibody antigen recognition and HLA-I peptide binding, and FMC63 CAR-T-cell killing, as reported in the version 2 abstract.
- Still unknown: Only the abstract, PMC version header and original-server corresponding-institution metadata were assessed; full author-affiliation list and full paper were not reviewed. Preserve ID.
- AI role: A pretrained protein generator, steered by ProVADA's annealing sampler toward externally defined properties while preserving functional constraints.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13742580/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.1101%2F2025.07.11.664238%22&resultType=core&format=json · https://api.biorxiv.org/details/biorxiv/10.1101/2025.07.11.664238
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.